Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (13)

2018

  1. Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

    British Journal of Cancer, Vol. 119, Núm. 12, pp. 1464-1470

2015

  1. Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy

    Molecular Diagnosis and Therapy, Vol. 19, Núm. 6, pp. 397-408

2014

  1. Oncological translational research in the Spanish national health system: The INTRO study

    Clinical and Translational Oncology, Vol. 16, Núm. 8, pp. 686-695

2005

  1. A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours

    Cancer Chemotherapy and Pharmacology, Vol. 55, Núm. 5, pp. 453-460

2003

  1. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

    Human Mutation, Vol. 22, Núm. 4, pp. 301-312

2002

  1. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  2. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

    Cancer, Vol. 95, Núm. 4, pp. 751-757

1997

  1. Combination of oral idarubicin and prednimustine in advanced breast cancer: A phase II study

    European Journal of Cancer Part A, Vol. 33, Núm. 2, pp. 312-315

1996

  1. Acute and anticipatory emesis in breast cancer patients

    Supportive Care in Cancer, Vol. 4, Núm. 5, pp. 370-377

1990

  1. Short report: Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone

    Annals of Oncology, Vol. 1, Núm. 5, pp. 379-380

1973

  1. CONDUCTA DE LAS INMUNOGLOBULINAS Y OTRAS PROTEINAS PLASMATICAS EN LOS LINFOMAS MALIGNOS ESTUDIADAS POR METODOS INMUNOLOGICOS

    Revista Clinica Espanola, Vol. 129, Núm. 3, pp. 231-238

  2. HETEROGENEIDAD DE FACTORES BLASTOGENICOS SEGREGADOS POR LOS LINFOCITOS ESTUDIADOS 'IN VITRO'

    Revista Clinica Espanola, Vol. 131, Núm. 4, pp. 285-292

  3. PROTEINAS DEL MOCO BRONQUIAL EN EL ASMA INTRINSECO

    Revista Clinica Espanola, Vol. 130, Núm. 1, pp. 39-40